San Diego, CA, United States of America

Daniel J Von Seggern

This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel J Von Seggern. Retrieved from https://idiyas.com/inventor/daniel-j-von-seggern

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel J Von Seggern

Introduction

Daniel J Von Seggern is a notable inventor based in San Diego, CA. He has made significant contributions to the field of gene therapy, particularly through his innovative work with adenovirus vectors. His research has implications for the development of targeted therapies that can improve patient outcomes.

Latest Patents

Daniel J Von Seggern holds a patent for "Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use." This invention relates to methods for gene therapy, especially adenovirus-based gene therapy. It includes novel nucleic acid constructs and packaging cell lines that facilitate the development of high-capacity and targeted vectors. The patent also discloses various high-capacity adenovirus vectors and related compositions, including kits that utilize the disclosed cell lines and vectors. Furthermore, it outlines methods for preparing and using these vectors, cell lines, and kits.

Career Highlights

Daniel J Von Seggern is affiliated with the Scripps Research Institute, where he has been involved in groundbreaking research. His work has contributed to advancements in gene therapy, showcasing his commitment to improving medical treatments through innovative technologies.

Collaborations

One of his notable collaborators is Glen R Nemerow, with whom he has worked on various projects related to adenovirus vectors and gene therapy.

Conclusion

Daniel J Von Seggern's contributions to the field of gene therapy through his patent and research at the Scripps Research Institute highlight his role as an influential inventor. His work continues to pave the way for advancements in targeted therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…